The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72384-7 · Cited by 1,608
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436
Functional domains of the human estrogen receptor
Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., & Chambon, P. (1987) · Cell · doi:10.1016/0092-8674(87)90581-2 · Cited by 1,316
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72307-0 · Cited by 1,282
Breast cancer and hormone-replacement therapy: the Million Women Study
Beral, V., Banks, E., Reeves, G., & Bull, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14596-5 · Cited by 1,273
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Kousteni, S., Bellido, T., Plotkin, L. I., O'Brien, C. A., Bodenner, D. L., Han, L., Han, K., DiGregorio, G. B., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,113
Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P., & Mark, M. (2000) · Development · doi:10.1242/dev.127.19.4277 · Cited by 1,064
Ellis, M. J., Coop, A., Singh, B., Mauriac, L., Llombert-Cussac, A., Jänicke, F., Miller, W. R., Evans, D. B., Dugan, M., Brady, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3808 · Cited by 1,060
Mouridsen, H., Gershanovich, M., Sun, Y., Pérez-Carrión, R., Boni, C., Monnier, A., Apffelstaedt, J., Smith, R., Sleeboom, H. P., Jänicke, F., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.10.2596 · Cited by 1,015
Bunone, G., Briand, P. A., Miksicek, R. J., & Picard, D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00571.x · Cited by 986
The nuclear receptor ligand-binding domain: structure and function
Moras, D., & Gronemeyer, H. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80015-x · Cited by 843
Berry, M., Metzger, D., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07469.x · Cited by 767
Bardou, V.-J., Arpino, G., Elledge, R. M., Osborne, C. K., & Clark, G. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.099 · Cited by 752
Kousteni, S. (2001) · Cell · doi:10.1016/s0092-8674(02)08100-x · Cited by 746
Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ
Stein, B., & Yang, M. X. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4971 · Cited by 704
‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer
Pike, M. C., Krailo, M. D., Henderson, B. E., Casagrande, J. T., & Hoel, D. G. (1983) · Nature · doi:10.1038/303767a0 · Cited by 697
Basic Guide to the Mechanisms of Antiestrogen Action
Macgregor, J. I., & Jordan, V. C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01358-9 · Cited by 694
Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells
PIETRAS, R. J., & SZEGO, C. M. (1977) · Nature · doi:10.1038/265069a0 · Cited by 691
Cauley, J. A., Norton, L., Lippman, M. E., Eckert, S., Krueger, K. A., Purdie, D. W., Farrerons, J., Karasik, A., Mellstrom, D., Ng, K. W., et al. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1006478317173 · Cited by 678
Gruvberger-Saal, S. K., Ringnér, M., Chen, Y., Panavally, S., Saal, L. H., Borg, Å., Fernö, M., Peterson, C., & Meltzer, P. S. (2001) · PubMed · Cited by 673
Osborne, C. K., Pippen, J., Jones, S. E., Parker, L. M., Ellis, M., Come, S., Gertler, S. Z., May, J. T., Burton, G., Dimery, I., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.058 · Cited by 642
Dissociation between steroid receptor expression and cell proliferation in the human breast.
Clarke, R. B., Howell, A., Potten, C. S., & Anderson, E. J. (1997) · PubMed · Cited by 625
(1990) · PubMed · Cited by 612
Insights from the study of animals lacking functional estrogen receptor
Korach, K. (1994) · Science · doi:10.1126/science.7985022 · Cited by 578
Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.
Roger, P., Sahla, M. E., Mäkelä, S., Gustafsson, J. A., Baldet, P., & Rochefort, H. (2001) · PubMed · Cited by 551
Immunolocalisation of oestrogen receptor beta in human tissues
Taylor, A., & Al-Azzawi, F. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0240145 · Cited by 529
Clinical, Cellular, and Molecular Aspects of Cancer Invasion
Mareel, M., & Leroy, A. (2003) · Physiological Reviews · doi:10.1152/physrev.00024.2002 · Cited by 524
Thompson, E. W., Paik, S., Brünner, N., Sommers, C. L., Zugmaier, G., Clarke, R., Shima, T. B., Torri, J., Donahue, S., Lippman, M. E., et al. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041500314 · Cited by 523
Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex
Gaub, M.-P., Bellard, M., Scheuer, I., Chambon, P., & Sassone-Corsi, P. (1990) · Cell · doi:10.1016/0092-8674(90)90422-b · Cited by 468
Ogawa, S. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.15.3505 · Cited by 448
Steroid hormone receptors in breast cancer management
Osborne, C. K. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006132427948 · Cited by 438
Functional Synergy between the Transcription Factor Sp1 and the Estrogen Receptor
Porter, W. W., Saville, B., Hoivik, D. J., & Safe, S. H. (1997) · Molecular Endocrinology · doi:10.1210/me.11.11.1569 · Cited by 428
Estrogen receptor beta--a new dimension in estrogen mechanism of action
Gustafsson, J. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1630379 · Cited by 423
Endocrine Pharmacology of Antiestrogens as Antitumor Agents*
JORDAN, V. C., & MURPHY, C. S. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-4-578 · Cited by 400
Growth Factors in Breast Cancer
DICKSON, R. B., & LIPPMAN, M. E. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-5-559 · Cited by 388
Estrogen receptor β acts as a dominant regulator of estrogen signaling
Pettersson, K., Delaunay, F., & Gustafsson, J.-Å. (2000) · Oncogene · doi:10.1038/sj.onc.1203828 · Cited by 362
Estrogen receptors α and β in the rodent mammary gland
Saji, S., Jensen, E. V., Nilsson, S., Rylander, T., Warner, M., & Gustafsson, J.-Å. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.337 · Cited by 357
Estrogen and Angiogenesis: A Review
Losordo, D. W., & Isner, J. M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.6 · Cited by 352
Analysis of Loss of Heterozygosity in 399 Premalignant Breast Lesions at 15 Genetic Loci
O'Connell, P., Pekkel, V., Allred, D. C., Fuqua, S. A. W., Osborne, C. K., & Clark, G. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.697 · Cited by 340
Lee, A. V. (1999) · Molecular Endocrinology · doi:10.1210/me.13.5.787 · Cited by 340
Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells
Doisneau-Sixou, S. F., Sergio, C. M., Carroll, J. S., Hui, R., Musgrove, E. A., & Sutherland, R. L. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100179 · Cited by 333
Robertson, J. F. R., Osborne, C. K., Howell, A., Jones, S. E., Mauriac, L., Ellis, M., Kleeberg, U. R., Come, S. E., Vergote, I., Gertler, S., et al. (2003) · Cancer · doi:10.1002/cncr.11468 · Cited by 315
Ray, A., Prefontaine, K. E., & Ray, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99966-7 · Cited by 301
Zhang, Q., Borg, Å., Wolf, D. M., Oesterreich, S., & Fuqua, S. A. W. (1997) · PubMed · Cited by 291
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions.
Fuqua, S. A. W., Wiltschke, C., ZHANG, Q. X., Borg, Å., Castles, C. G., Friedrichs, W. E., Hopp, T., Hilsenbeck, S. G., Mohsin, S. K., O'Connell, P., et al. (2000) · PubMed · Cited by 278
Estrogen Receptor-Positive Proliferating Cells in the Normal and Precancerous Breast
Shoker, B. S., Jarvis, C., Clarke, R. B., Anderson, E., Hewlett, J., Davies, M. P. A., Sibson, D. R., & Sloane, J. P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65498-3 · Cited by 278
Järvinen, T. A. H., Pelto-Huikko, M., Holli, K., & Isola, J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64702-5 · Cited by 277
Fisher, B., Anderson, S., Tan-Chiu, E., Wolmark, N., Wickerham, D. L., Fisher, E. R., Dimitrov, N. V., Atkins, J. N., Abramson, N., Merajver, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.931 · Cited by 272
Green, S., Kumar, V., Theulaz, I., Wahli, W., & Chambon, P. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03168.x · Cited by 270
Roodi, N., Bailey, L. R., Kao, W.-Y., Verrier, C. S., Yee, C. J., Dupont, W. D., & Parl, F. F. (1995) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/87.6.446 · Cited by 266
Jiang, S.-Y., & Jordan, V. C. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.8.580 · Cited by 261
Estrogen receptor beta in breast cancer.
Palmieri, C., Cheng, G. J., Saji, S., Zelada-Hedman, M., W√§rri, A., Weihua, Z., Van Noorden, S., Wahlstrom, T., Coombes, R. C., Warner, M., et al. (2002) · Endocrine-related cancer · doi:10.1677/erc.0.0090001 · Cited by 257
Estrogen Receptor Expression in Benign Breast Epithelium and Breast Cancer Risk
Khan, S. A., Rogers, M. A. M., Khurana, K. K., Meguid, M. M., & Numann, P. J. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.1.37 · Cited by 251
A comparison of transcriptional activation by ERα and ERβ
Cowley, S. M., & Parker, M. G. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00055-2 · Cited by 243
ICI 182,780, a new antioestrogen with clinical potential
Wakeling, A. E., & Bowler, J. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90204-v · Cited by 242
Kollmannsberger, C., Beyer, J., Droz, J. P., Harstrick, A., Hartmann, J. T., Biron, P., Fléchon, A., Schöffski, P., Kuczyk, M., Schmoll, H. J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3386 · Cited by 201
Hormonal Pathogenesis of Adenocarcinoma of the Breast
Lacassagne, A. (1936) · The American Journal of Cancer · doi:10.1158/ajc.1936.217 · Cited by 194
Pegram, M. D., & Slamon, D. J. (1999) · PubMed · Cited by 185
Katzenellenbogen, B. S., & Katzenellenbogen, J. A. (2002) · Science · doi:10.1126/science.1070442 · Cited by 179
Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters.
Fuqua, S. A. W., Schiff, R., Parra, I., Moore, J. T., Mohsin, S. K., Osborne, C. K., Clark, G. M., & Allred, D. C. (2003) · PubMed · Cited by 178
Garcia, M., Derocq, D., Freiss, G., & Rochefort, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11538 · Cited by 175
Self-citationEstrogen regulation of cell cycle progression in breast cancer cells
Prall, O. W. J., Rogan, E. M., & Sutherland, R. L. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00021-1 · Cited by 166
Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention
Park, W., & Jordan, V. C. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02282-7 · Cited by 158
Fisher, B., Jeong, J., Dignam, J. J., Anderson, S., Mamounas, E. P., Wickerham, D. L., & Wolmark, N. (2001) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003463 · Cited by 146
Estrogens, BRCA1, and breast cancer.
Hilakivi‐Clarke, L. (2000) · PubMed · Cited by 138
Adams, J. B., Garcia, M., & Rochefort, H. (1981) · PubMed · Cited by 138
Self-citationMcDonnell, D. P., Connor, C. E., Wijayaratne, A., Chang, C.-Y., & Norris, J. D. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.295 · Cited by 130
Characterization of the Physical Interaction between Estrogen Receptor α and JUN Proteins
Teyssier, C., Belguise, K., Galtier, F., & Chalbos, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101806200 · Cited by 128
Saji, S., Omoto, Y., Shimizu, C., Warner, M. N., Hayashi, Y. K., Horiguchi, S.-I., Watanabe, T., Hayashi, S., Gustafsson, J.-Å., & Toi, M. (2002) · PubMed · Cited by 121
Risk factors for breast cancer development
Henderson, I. C. (1993) · Cancer · doi:10.1002/1097-0142(19930315)71:6+<2127::aid-cncr2820711602>3.0.co;2-2 · Cited by 115
Albini, A., Graf, J., Kitten, G. T., Kleinman, H. K., Martin, G. R., Veillette, A., & Lippman, M. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8182 · Cited by 114
Bracke, M. E., Charlier, C., Bruyneel, E. A., Labit, C., Mareel, M. M., & Castronovo, V. (1994) · PubMed · Cited by 112
The estrogenic and antiestrogenic activities of androgens in female target tissues.
Rochefort, H., & Garcia, M. (1983) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(83)90013-x · Cited by 107
Self-citationHayashido, Y., Lucas, A., Rougeot, C., Godyna, S., Argraves, W. S., & Rochefort, H. (1998) · International Journal of Cancer · Cited by 104
Estrogen receptor mediated inhibition of cancer cell invasion and motility: An overview
Rochefort, H., Platet, N., Hayashido, Y., Derocq, D., Lucas, A., Cunat, S., & Garcia, M. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00010-7 · Cited by 103
Self-citationEstrogen-mediated down-regulation of E-cadherin in breast cancer cells.
Oesterreich, S., Deng, W., Jiang, S., Cui, X., Ivanova, M. M., Schiff, R., Kang, K., Hadsell, D. L., Behrens, J., & Lee, A. V. (2003) · PubMed · Cited by 102
Estradiol attenuates directed migration of vascular smooth muscle cells in vitro.
Kolodgie, F. D., Jacob, A., Wilson, P. S., Carlson, G. C., Farb, A. A., Verma, A., & Virmani, R. (1996) · Europe PMC (PubMed Central) · Cited by 100
The Essential Role of the Aromatase/P450arom
Meinhardt, U. J., & Mullis, P. E. (2002) · Seminars in Reproductive Medicine · doi:10.1055/s-2002-35374 · Cited by 88
Unliganded and Liganded Estrogen Receptors Protect against Cancer Invasion via Different Mechanisms
Platet, N., Cunat, S., Chalbos, D., Rochefort, H., & Garcia, M. (2000) · Molecular Endocrinology · doi:10.1210/me.14.7.999 · Cited by 88
Self-citationVogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., & Wolmark, N. (2002) · Clinical Breast Cancer · doi:10.3816/cbc.2002.n.020 · Cited by 87
Inhibition of aromatase: insights from recent studies
Santen, R. J. (2003) · Steroids · doi:10.1016/s0039-128x(03)00096-5 · Cited by 83
Tamoxifen Therapy for Primary Breast Cancer and Risk of Contralateral Breast Cancer
Li, C. I., Malone, K. E., Weiss, N. S., & Daling, J. R. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.1008 · Cited by 83
Platet, N., Prévostel, C., Derocq, D., BRESSION, D., Rochefort, H., & Garcia, M. (1998) · International Journal of Cancer · Cited by 78
Self-citationde Medeiros, S. R. B., Krey, G. D., Hihi, A. K., & Wahli, W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.18250 · Cited by 78
Ms, S., Garcia, M., Pujol, P., Fontana, J. A., & Rochefort, H. (1994) · PubMed · Cited by 75
Self-citationLaïos, I., Journé, F., Laurent, G., Nonclercq, D., Toillon, R., Seo, H., & Leclercq, G. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.09.011 · Cited by 48
Desai, A., Luqmani, Y., Walters, J., Coope, R. C., Dagg, B. M., Gomm, J., Pace, P., Rees, C., Thirunavukkarasu, V., Shousha, S., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.202 · Cited by 43
Robertson, F. R., Osborne, C. K., Howell, A., Jones, S. E., Mauriac, L., Ellis, M., Kleeberg, U. R., Come, S. E., Vergote, I. B., Gertler, S., et al. (2004) · The Women s Oncology Review · doi:10.3109/14733400410001728474 · Cited by 39
Caristi, S., Galera, J. L., Matarese, F., Imai, M., Caporali, S., Cancemi, M., Altucci, L., Cicatiello, L., Teti, D. V., Bresciani, F., et al. (2001) · PubMed · Cited by 37
A Role for Sex Steroids in Autoimmune Diseases: A Working Hypothesis and Supporting Data
CASTAGNETTA, L. A. M., Granata, O. M., Traina, A., Cocciadiferro, L., Saetta, A., Stefano, R., Cutolo, M., & Carruba, G. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04215.x · Cited by 30
Zhu, K., Bernard, L. J., Levine, R. S., & Williams, S. M. (1997) · Medical Hypotheses · doi:10.1016/s0306-9877(97)90255-3 · Cited by 29
Gutman, M., Couillard, S., Labrie, F., Candas, B., & Labrie, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10803 · Cited by 5
Cited by
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
The different roles of ER subtypes in cancer biology and therapy
Thomas, C., & Gustafsson, J.-Å. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3093 · Cited by 654
Oktay, K., Hourvitz, A., Sahin, G., Oktem, O., Safro, B., Cil, A., & Bang, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0962 · Cited by 421
Amphiregulin is an essential mediator of estrogen receptor α function in mammary gland development
Ciarloni, L., Mallepell, S., & Brisken, C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611647104 · Cited by 316
Proliferating Cholangiocytes: A Neuroendocrine Compartment in the Diseased Liver
Alvaro, D., Mancino, M. G., Glaser, S., Gaudio, E., Marzioni, M., Francis, H., & Alpini, G. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.07.023 · Cited by 304
Metadata
- Authors
- Platet, N., Cathiard, A. M., Gleizes, M., & Garcia, M.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2004-07
- Volume
- 51
- Issue
- 1
- Pages
- 55-67
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2009504099
- Cited by
- 367
- References
- 105
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.